Literature DB >> 19205727

Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity.

J Verine.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19205727     DOI： 10.1007/s00428-009-0741-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  5 in total

1.  Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Authors:  Satish K Tickoo; Mariza N dePeralta-Venturina; Lara R Harik; Heath D Worcester; Mohamed E Salama; Andrew N Young; Holger Moch; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

2.  Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor.

Authors:  M Michal; O Hes; F Havlicek
Journal:  Ann Diagn Pathol       Date:  2000-10       Impact factor: 2.090

3.  Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.

Authors:  Stefano Gobbo; John N Eble; David J Grignon; Guido Martignoni; Gregory T MacLennan; Rajal B Shah; Shaobo Zhang; Matteo Brunelli; Liang Cheng
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

4.  Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity.

Authors:  Kien T Mai; Derek M Kohler; Eric C Belanger; Susan J Robertson; Don Wang
Journal:  Pathology       Date:  2008-08       Impact factor: 5.306

5.  Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity.

Authors:  M Michal; O Hes; J Nemcova; R Sima; N Kuroda; S Bulimbasic; M Franco; N Sakaida; D Danis; D V Kazakov; C Ohe; M Hora
Journal:  Virchows Arch       Date:  2008-11-20       Impact factor: 4.064
  5 in total
  4 in total

1.  Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma.

Authors:  Michal Michal; Ondrej Hes; Naoto Kuroda; Dmitry V Kazakov; Milan Hora
Journal:  Virchows Arch       Date:  2009-05-27       Impact factor: 4.064

2.  Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.

Authors:  Karl-Friedrich Deml; Hans-Ulrich Schildhaus; Eva Compérat; Adriana von Teichman; Martina Storz; Peter Schraml; Joseph V Bonventre; Falko Fend; Barbara Fleige; Andreas Nerlich; Helmut E Gabbert; Nikolaus GaBler; Rainer Grobholz; Seife Hailemariam; Raoul Hinze; Ruth Knüchel; Benoit Lhermitte; Gabriella Nesi; Thomas Rüdiger; Guido Sauter; Holger Moch
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

3.  Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity.

Authors:  Sean R Williamson; Liang Cheng; John N Eble; Lawrence D True; Nilesh S Gupta; Mingsheng Wang; Shaobo Zhang; David J Grignon
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

Review 4.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.